While WGS sequences the entire genome, Prenatal Exome Sequencing focuses only on the exons, the 1–2% of the genome where ~85% of disease-causing mutations are found. This targeted approach offers a higher coverage of fetally relevant regions, increased diagnostic accuracy, faster turnaround time, and lower cost compared to WGS.
What is Prenatal Exome Sequencing?
Prenatal exome sequencing is a next generation sequencing (NGS)–based test that examines the protein-coding regions of the genome, known as exons. Although exons make up only a small fraction of the genome, they harbour approximately 85% of known disease-causing mutations. At MedGenome, we provide a validated sequencing pipeline combined with a robust interpretation system to ensure accurate and reliable clinical diagnosis. Prenatal exome sequencing enables the identification of genetic disorders in the developing fetus, supporting informed decision-making and personalised prenatal care.
Clinical Indications of Prenatal Exome Sequencing
- In cases where prenatal clinical findings or family history is suggestive of an underlying genetic etiology
- To confirm the suspected genetic diagnosis
- To guide reproductive planning and assessment of recurrence risk
Specifications
- Gene Count: Clinical Exome: 7,000+, Whole Exome: 20,000+, ExomeMAX: 20,000+.
- Design Size: 29.2 Mb (Clinical Exome), 43.2 Mb (Whole Exome), 62.4 Mb (ExomeMAX).
- On-Target Regions: On-Target Regions: 20 Mb (Clinical Exome), 36.5 Mb (Whole Exome), 47 Mb (ExomeMAX).
- Mitochondrial Genes: Optional in Clinical & Whole Exome; included in ExomeMAX.
- Variant Detection: SNVs, InDels & CNVs (all options).
- Pathogenic Variants Reported: HGMD / ClinVar; non-coding variants included.
- SAS-ATLAS Integration: Available in Clinical Exome and ExomeMAX.
- CNV Sensitivity: High, with enhanced detection in Clinical Exome and ExomeMAX.
- Validation Concordance: 100% across all platforms.
Key Highlights of MedGenome's Prenatal Exome Sequencing Test
Broad Inheritance Coverage
Detects variants linked to autosomal dominant, autosomal recessive, and X-linked disorders.
Cost-Effective for Complex Disorders
An ideal first-line test for conditions with overlapping or unclear fetal presentations.
Validated Mutation Reporting
Reports pathogenic variants referenced in OMIM and HGMD and captures both reported and previously unidentified mutations that may cause disease.
Get Genetic Counselling by Our Experts

Connect with Our Experts
MedGenome Patient Stories
MedGenome in the News
Please share your details to get
in touch with our experts.














